-

04:52:20 AM

TWST Stock News

TWST - Twist Bioscience Corp

08/05/22 7:30 AM

Nasdaq : TWST

earnings

Twist Bioscience Reports Fiscal Third Quarter 2022 Financial Results

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the third quarter of fiscal 2022 ended June 30, 2022. “We are the high quality, low cost leader and as the macroeconomic environment continues to...

RHEA-AI

neutral

08/03/22 8:00 AM

Nasdaq : TWST

conferences

Twist Bioscience to Present at Flash Memory Summit

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Steffen Hellmold, senior vice president, business development for data storage, will present at the Flash Memory Summit taking place August 2-4, 2022 at the Santa Clara Convention...

RHEA-AI

neutral

08/02/22 8:01 AM

Nasdaq : TWST

Twist Bioscience Highlights White Paper Sizing Future DNA Data Storage Market

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today shared a new white paper from Furthur Market Research 1 highlighting the dramatic need for new enterprise storage technologies that can be deployed more cost effectively at massive scale with...

RHEA-AI

neutral

08/02/22 8:00 AM

Nasdaq : TWST

conferences

Twist Bioscience and Biotia Receive Expanded Emergency Use Authorization to Report Genetic Variants of SARS-CoV-2

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Biotia, Inc., a company that uses proprietary analytical software for infectious...

RHEA-AI

neutral

08/01/22 8:00 AM

Nasdaq : TWST

conferences

Twist Bioscience to Present at UBS Genomics 2.0 and Medtech Innovations Summit

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Jim Thorburn, CFO of Twist Bioscience, and Patrick Finn, Ph.D., CCO of Twist Bioscience, will host a fireside chat and one-on-one meetings at the UBS Genomics 2.0 and Medtech Innovations...

RHEA-AI

neutral

07/18/22 8:00 AM

Nasdaq : TWST

conferencesearnings

Twist Bioscience to Report Fiscal 2022 Third Quarter Financial Results on Friday, August 5, 2022

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2022 third quarter ended June 30, 2022, before the opening of the market on Aug. 5, 2022. The company plans to hold a conference call and live...

RHEA-AI

neutral

07/14/22 8:00 AM

Nasdaq : TWST

Twist Bioscience Launches Monkeypox Virus Synthetic DNA Controls

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today launched two human monkeypox virus synthetic DNA controls 1. The Twist synthetic DNA controls include both known clades of the monkeypox virus, currently named the Congo Basin clade and the West...

RHEA-AI

very positive

07/13/22 8:03 AM

Nasdaq : TWST

DNAnexus and Twist Bioscience Collaborate to Provide Data Analysis Software for NGS Workflow

DNAnexus, Inc., a leading provider of cloud-based biomedical data analysis software serving the life sciences community, and Twist...

RHEA-AI

very positive

07/06/22 8:00 AM

Nasdaq : TWST

Twist Bioscience Opens New Twist Boston Location to Expand Antibody Discovery Capacity

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the opening of its new Twist Boston location in Quincy, Massachusetts. “This is a year of growth for Twist, as we work to bring the Factory of the Future online in Oregon while expanding our in vivo...

RHEA-AI

very positive

06/30/22 8:00 AM

Nasdaq : TWST

Twist Bioscience and Ildong Pharmaceutical Enter into a Collaboration to Enhance Antibody Discovery for Applications in Immuno-oncology

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Ildong Pharmaceutical, today announced an agreement under which Ildong will license a suite of Twist VHH antibody libraries to use to discover and develop...

RHEA-AI

very positive

1 2 3 4 5 6 7 8 9 10 Next

TWST Data

IndustryResearch and Development in Biotechnology
Websitewww.twistbioscience.com
CeoEmily Leproust
Security nameTwist Bioscience Corp
Issue typecs
SectorProfessional, Scientific, and Technical Services
Sic code2836
Employees525
Tags
- Health Technology
- Biotechnology
Address681 Gateway Blvd.
StateCalifornia
CitySouth San Francisco
Zip94080
CountryUS
Phone18007190671

About Twist Bioscience Corp

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by 'writing' DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.